Han Yusheng

SEC Form 4 insider trading activity

Han Yusheng has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Jul 2, 2026.

On the most recent filing, Han Yusheng is listed as Director at Burning Rock Biotech Ltd. Inside the rolling window, Han Yusheng reported 8 open-market purchases totaling $11.6M in BNR and no open-market sales. The largest disclosed transaction in the window is a purchase of 314,870 BNR shares on Mar 31, 2026, worth $5.5M.

Companies traded

Insider Buying

$11.6M

reported purchases (SEC code P)

Insider Selling

$0

reported sales (SEC code S)

Companies

1

in the rolling window

Source
BNRPurchase$216KJul 2SEC ↗
BNRPurchase$1.9MJul 2SEC ↗
BNRPurchase$1000KJul 2SEC ↗
BNRPurchase$780KJul 2SEC ↗
BNRPurchase$45KJul 2SEC ↗
BNRPurchase$2.0MJul 2SEC ↗
BNRPurchase$199KJul 2SEC ↗
BNRPurchase$5.5MApr 2SEC ↗
Showing 1–8 of 8
1 / 1

Frequently asked questions

How many SEC Form 4 filings has Han Yusheng made?

Han Yusheng has filed 2 SEC Form 4 filings (8 transaction rows) across 1 company since 2026.

Which companies does Han Yusheng trade?

Han Yusheng has filed SEC Form 4 disclosures for 1 company, including BNR.

When was Han Yusheng's most recent SEC Form 4 filing?

Han Yusheng's most recent SEC Form 4 filing on Tracefour is dated Jul 2, 2026.

What is Han Yusheng's total buy and sell value in the current window?

Inside the rolling retention window, Han Yusheng bought $11.6M and sold $0 based on SEC Form 4 filings.

What was Han Yusheng's largest disclosed transaction?

The largest disclosed transaction in the current window is a purchase of 314,870 BNR shares on 2026-03-31, worth $5.5M, per SEC Form 4 filings.